263 related articles for article (PubMed ID: 8047260)
1. Clinical aspects of motor fluctuations in Parkinson's disease.
Poewe WH
Neurology; 1994 Jul; 44(7 Suppl 6):S6-9. PubMed ID: 8047260
[TBL] [Abstract][Full Text] [Related]
2. Various aspects of motor fluctuations and their management in Parkinson's disease.
Mizuno Y; Kondo T; Mori H
Neurology; 1994 Jul; 44(7 Suppl 6):S29-34. PubMed ID: 8047258
[TBL] [Abstract][Full Text] [Related]
3. Motor complications associated with chronic levodopa therapy in Parkinson's disease.
Obeso JA; Grandas F; Vaamonde J; Luquin MR; Artieda J; Lera G; Rodriguez ME; Martinez-Lage JM
Neurology; 1989 Nov; 39(11 Suppl 2):11-9. PubMed ID: 2685647
[TBL] [Abstract][Full Text] [Related]
4. Presynaptic mechanisms of motor fluctuations in Parkinson's disease: a probabilistic model.
de la Fuente-Fernández R; Schulzer M; Mak E; Calne DB; Stoessl AJ
Brain; 2004 Apr; 127(Pt 4):888-99. PubMed ID: 14960500
[TBL] [Abstract][Full Text] [Related]
5. Treatment of Parkinson's disease: levodopa as the first choice.
Katzenschlager R; Lees AJ
J Neurol; 2002 Sep; 249 Suppl 2():II19-24. PubMed ID: 12375059
[TBL] [Abstract][Full Text] [Related]
6. [Motor complications in patients with Parkinson disease treated with levodopa].
Luquin MR; Obeso JA; Martínez-Lage JM
Neurologia; 1989; 4(1):4-11. PubMed ID: 2631806
[TBL] [Abstract][Full Text] [Related]
7. Motor fluctuations in Parkinson's disease: central pathophysiological mechanisms, Part II.
Mouradian MM; Juncos JL; Fabbrini G; Schlegel J; Bartko JJ; Chase TN
Ann Neurol; 1988 Sep; 24(3):372-8. PubMed ID: 3228271
[TBL] [Abstract][Full Text] [Related]
8. The impact of treatment with levodopa on Parkinson's disease.
Shaw KM; Lees AJ; Stern GM
Q J Med; 1980; 49(195):283-93. PubMed ID: 7465763
[TBL] [Abstract][Full Text] [Related]
9. Treating motor fluctuations with controlled-release levodopa preparations.
Koller WC; Pahwa R
Neurology; 1994 Jul; 44(7 Suppl 6):S23-8. PubMed ID: 8047257
[TBL] [Abstract][Full Text] [Related]
10. Motor fluctuations in Parkinson's disease: central pathophysiological mechanisms, Part I.
Fabbrini G; Mouradian MM; Juncos JL; Schlegel J; Mohr E; Chase TN
Ann Neurol; 1988 Sep; 24(3):366-71. PubMed ID: 3228270
[TBL] [Abstract][Full Text] [Related]
11. Levodopa-induced dyskinesias in Parkinson's disease: is sensitization reversible?
Bejjani BP; Arnulf I; Demeret S; Damier P; Bonnet AM; Houeto JL; Agid Y
Ann Neurol; 2000 May; 47(5):655-8. PubMed ID: 10805339
[TBL] [Abstract][Full Text] [Related]
12. Apomorphine monotherapy in the treatment of refractory motor complications of Parkinson's disease: long-term follow-up study of 64 patients.
Manson AJ; Turner K; Lees AJ
Mov Disord; 2002 Nov; 17(6):1235-41. PubMed ID: 12465062
[TBL] [Abstract][Full Text] [Related]
13. Duodenal levodopa infusion monotherapy vs oral polypharmacy in advanced Parkinson disease.
Nyholm D; Nilsson Remahl AI; Dizdar N; Constantinescu R; Holmberg B; Jansson R; Aquilonius SM; Askmark H
Neurology; 2005 Jan; 64(2):216-23. PubMed ID: 15668416
[TBL] [Abstract][Full Text] [Related]
14. Ten years' experience with enteral levodopa infusions for motor fluctuations in Parkinson's disease.
Syed N; Murphy J; Zimmerman T; Mark MH; Sage JI
Mov Disord; 1998 Mar; 13(2):336-8. PubMed ID: 9539350
[TBL] [Abstract][Full Text] [Related]
15. Pathogenesis of dyskinesias in Parkinson's disease.
Mouradian MM; Heuser IJ; Baronti F; Fabbrini G; Juncos JL; Chase TN
Ann Neurol; 1989 May; 25(5):523-6. PubMed ID: 2774496
[TBL] [Abstract][Full Text] [Related]
16. Clinical and pathophysiologic aspects of late levodopa failure.
Poewe W
Neurology; 1993 Dec; 43(12 Suppl 6):S28-30. PubMed ID: 8264908
[TBL] [Abstract][Full Text] [Related]
17. Levodopa-induced dyskinesias in Parkinson's disease phenomenology and pathophysiology.
Marconi R; Lefebvre-Caparros D; Bonnet AM; Vidailhet M; Dubois B; Agid Y
Mov Disord; 1994 Jan; 9(1):2-12. PubMed ID: 8139601
[TBL] [Abstract][Full Text] [Related]
18. Recognition and treatment of response fluctuations in Parkinson's disease: review article.
Verhagen Metman L
Amino Acids; 2002; 23(1-3):141-5. PubMed ID: 12373528
[TBL] [Abstract][Full Text] [Related]
19. Drug-induced motor complications in dopa-responsive dystonia: implications for the pathogenesis of dyskinesias and motor fluctuations.
de la Fuente-Fernández R
Clin Neuropharmacol; 1999; 22(4):216-9. PubMed ID: 10442251
[TBL] [Abstract][Full Text] [Related]
20. [Changes in the nigrostriatal dopamine receptor compartment after continuous dopaminergic infusions in Parkinson disease].
Baronti F; Ruggieri S; Mouradian MM; Bonamartini A; Bocciarelli P; De Pandis MF; Chase TN; Agnoli A
Riv Neurol; 1991; 61(6):210-4. PubMed ID: 1813972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
